30 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
- RxCUI
- 1487527
- RxNorm name
- 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
- Display name
- 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
- Full name
- 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Umeclidinium and Vilanterol Ellipta | UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | Prasco Laboratories | 6de414b1-f707-4b98-9e4b-742032ec90af | 2024-11-22 | Warnings, Adverse reactions | 1487527 |
| Anoro Ellipta | UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | GlaxoSmithKline LLC | 2dbd0671-c565-40c5-bf0f-e324db26799c | 2023-06-02 | Warnings, Adverse reactions | 1487527 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2dbd0671-c565-40c5-bf0f-e324db26799c | 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler | SCD | 29 | These highlights do not include all the information needed to use ANORO ELLIPTA safely and effectively. See full prescribing information for ANORO ELLIPTA. ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder), for oral inhalation use Initial U.S. Approval: 2013 | 20230602 |
| 2dbd0671-c565-40c5-bf0f-e324db26799c | umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT 30 ACTUAT Dry Powder Inhaler | SY | 29 | These highlights do not include all the information needed to use ANORO ELLIPTA safely and effectively. See full prescribing information for ANORO ELLIPTA. ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder), for oral inhalation use Initial U.S. Approval: 2013 | 20230602 |
| 2dbd0671-c565-40c5-bf0f-e324db26799c | umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | PSN | 29 | These highlights do not include all the information needed to use ANORO ELLIPTA safely and effectively. See full prescribing information for ANORO ELLIPTA. ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder), for oral inhalation use Initial U.S. Approval: 2013 | 20230602 |
| 6de414b1-f707-4b98-9e4b-742032ec90af | umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters | PSN | 3 | These highlights do not include all the information needed to use Umeclidinium and Vilanterol ELLIPTA safely and effectively. See full prescribing information for Umeclidinium and Vilanterol ELLIPTA. Umeclidinium and Vilanterol ELLIPTA inhalation powder, for oral inhalation use Initial U.S. Approval: 2013 | 20241122 |
| 6de414b1-f707-4b98-9e4b-742032ec90af | 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler | SCD | 3 | These highlights do not include all the information needed to use Umeclidinium and Vilanterol ELLIPTA safely and effectively. See full prescribing information for Umeclidinium and Vilanterol ELLIPTA. Umeclidinium and Vilanterol ELLIPTA inhalation powder, for oral inhalation use Initial U.S. Approval: 2013 | 20241122 |
| 6de414b1-f707-4b98-9e4b-742032ec90af | umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT 30 ACTUAT Dry Powder Inhaler | SY | 3 | These highlights do not include all the information needed to use Umeclidinium and Vilanterol ELLIPTA safely and effectively. See full prescribing information for Umeclidinium and Vilanterol ELLIPTA. Umeclidinium and Vilanterol ELLIPTA inhalation powder, for oral inhalation use Initial U.S. Approval: 2013 | 20241122 |